Liminatus Pharma, Inc. (LIMNW)
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Liminatus Pharma, Inc. Warrants
+13.96%$0.0400
Prev close$0.0351+13.96%Close$0.0400
Mkt Cap$54K
EV-
Float-
O/S1.34M
VOL251 sh
$ Vol$10
RVOL1.31×
Inst Own-
Net Cash/Sh-
Dilution
MCap$54KFloat-O/S1.34M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.0450 | 0.0450 | 0.0450 | 0.0450 | 1 |
| Nov 12, 2026 | 0.0400 | 0.0400 | 0.0400 | 0.0400 | 251 |
| Nov 10, 2026 | 0.0351 | 0.0400 | 0.0351 | 0.0351 | 117 |
| Nov 6, 2026 | 0.0350 | 0.0351 | 0.0350 | 0.0351 | 600 |
| Nov 2, 2026 | 0.0352 | 0.0352 | 0.0352 | 0.0352 | 45 |
| Oct 28, 2026 | 0.0400 | 0.0400 | 0.0400 | 0.0400 | 138 |
| Oct 16, 2026 | 0.0500 | 0.0500 | 0.0500 | 0.0500 | 55 |
| Oct 15, 2026 | 0.0400 | 0.0400 | 0.0400 | 0.0400 | 213 |
| Oct 12, 2026 | 0.0435 | 0.0435 | 0.0435 | 0.0435 | 100 |
| Oct 8, 2026 | 0.0499 | 0.0499 | 0.0497 | 0.0497 | 800 |
| Oct 7, 2026 | 0.0440 | 0.0440 | 0.0370 | 0.0370 | 3,650 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(24)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
CANTOR FITZGERALD, L. P. LIMNW | 875.8K | -- | 13F |
ARISTEIA CAPITAL, L.L.C. LIMNW | 319.5K | -- | 13F |
Linden Advisors LP LIMNW | 268.2K | -- | 13F |
Saba Capital Management, L.P. LIMNW | 233.8K | -- | 13F |
MOORE CAPITAL MANAGEMENT, LP LIMNW | 125.0K | -- | 13F |
Polar Asset Management Partners Inc. LIMNW | 122.7K | -- | 13F |
MMCAP International Inc. SPC LIMNW | 111.7K | -- | 13F |
NOMURA HOLDINGS INC LIMNW | 97.3K | -- | 13F |
D. E. Shaw & Co., Inc. LIMNW | 83.4K | -- | 13F |
Blue Owl Capital Holdings LP LIMNW | 50.0K | -- | 13F |
Sources: 13F
Insiders & Institutional Holders
About
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer.
The company's headquarters are located in La Palma, California.
Key Metrics
Market Cap$53,728
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 1.34M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
Country
US
IPO DateMay 1, 2025
Shares Outstanding1.34M
Authorized Shares
Float-
52-Week Range
$0.0300$0.1949
$0.0400(6th percentile)
Volume
Average Daily Volume192
251 today vs 192 avg(+31%)
30d Avg
192
60d Avg
541
90d Avg
1.34K
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...
Liminatus Pharma, Inc. (NASDAQ: LIMNW) traded at $0.0400 on Nov 12, 2026, up 13.96% from the previous close of $0.0351. 52-week range: $0.0300 to $0.1949. The company is in the Healthcare sector (Biotechnology).